• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于低剂量CT肺癌筛查的人工智能:应用场景比较

Artificial Intelligence for Low-Dose CT Lung Cancer Screening: Comparison of Utilization Scenarios.

作者信息

Lee Meesun, Hwang Eui Jin, Lee Jong Hyuk, Nam Ju Gang, Lim Woo Hyeon, Park Hyungin, Park Chang Min, Choi Hyewon, Park Jongsoo, Goo Jin Mo

机构信息

Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.

Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

AJR Am J Roentgenol. 2025 Jul;225(1):e2532829. doi: 10.2214/AJR.25.32829. Epub 2025 Apr 16.

DOI:10.2214/AJR.25.32829
PMID:40237429
Abstract

. Artificial intelligence (AI) tools for evaluating low-dose CT (LDCT) lung cancer screening examinations are used predominantly for assisting radiologists' interpretations. Alternate utilization scenarios (e.g., use of AI as a prescreener or backup) warrant consideration. . The purpose of this study was to evaluate the impact of different AI utilization scenarios on diagnostic outcomes and interpretation times for LDCT lung cancer screening. . This retrospective study included 366 individuals (358 men, 8 women; mean age, 64 years) who underwent LDCT from May 2017 to December 2017 as part of an earlier prospective lung cancer screening trial. Examinations were interpreted by one of five readers, who reviewed their assigned cases in two sessions (with and without a commercial AI computer-aided detection tool). These interpretations were used to reconstruct simulated AI utilization scenarios: as an assistant (i.e., radiologists interpret all examinations with AI assistance), as a prescreener (i.e., radiologists only interpret examinations with a positive AI result), or as backup (i.e., radiologists reinterpret examinations when AI suggests a missed finding). A group of thoracic radiologists determined the reference standard. Diagnostic outcomes and mean interpretation times were assessed. Decision-curve analysis was performed. . Compared with interpretation without AI (recall rate, 22.1%; per-nodule sensitivity, 64.2%; per-examination specificity, 88.8%; mean interpretation time, 164 seconds), AI as an assistant showed higher recall rate (30.3%; < .001), lower per-examination specificity (81.1%), and no significant change in per-nodule sensitivity (64.8%; = .86) or mean interpretation time (161 seconds; = .48); AI as a prescreener showed lower recall rate (20.8%; = .02) and mean interpretation time (143 seconds; = .001), higher per-examination specificity (90.3%; = .04), and no significant difference in per-nodule sensitivity (62.9%; = .16); and AI as a backup showed increased recall rate (33.6%; < .001), per-examination sensitivity (66.4%; < .001), and mean interpretation time (225 seconds; = .001), with lower per-examination specificity (79.9%; < .001). Among scenarios, only AI as a prescreener demonstrated higher net benefit than interpretation without AI; AI as an assistant had the least net benefit. . Different AI implementation approaches yield varying outcomes. The findings support use of AI as a prescreener as the preferred scenario. . An approach whereby radiologists only interpret LDCT examinations with a positive AI result can reduce radiologists' workload while preserving sensitivity.

摘要

用于评估低剂量CT(LDCT)肺癌筛查检查的人工智能(AI)工具主要用于辅助放射科医生的解读。其他使用场景(例如,将AI用作预筛查工具或备用工具)值得考虑。本研究的目的是评估不同AI使用场景对LDCT肺癌筛查诊断结果和解读时间的影响。这项回顾性研究纳入了366名个体(358名男性,8名女性;平均年龄64岁),他们在2017年5月至2017年12月期间接受了LDCT检查,这是一项早期前瞻性肺癌筛查试验的一部分。检查由五名阅片者之一进行解读,他们分两个阶段(使用和不使用商用AI计算机辅助检测工具)对分配给他们的病例进行审查。这些解读被用于重建模拟的AI使用场景:作为助手(即放射科医生在AI辅助下解读所有检查)、作为预筛查工具(即放射科医生仅解读AI结果为阳性的检查)或作为备用工具(即当AI提示有漏诊发现时,放射科医生重新解读检查)。一组胸科放射科医生确定了参考标准。评估了诊断结果和平均解读时间。进行了决策曲线分析。与不使用AI的解读相比(召回率22.1%;每结节敏感度64.2%;每次检查特异度88.8%;平均解读时间164秒),AI作为助手时召回率更高(30.3%;P<0.001),每次检查特异度更低(81.1%),每结节敏感度(64.8%;P = 0.86)或平均解读时间(161秒;P = 0.48)无显著变化;AI作为预筛查工具时召回率更低(20.8%;P = 0.02)且平均解读时间更短(143秒;P = 0.001),每次检查特异度更高(90.3%;P = 0.04),每结节敏感度无显著差异(62.9%;P = 0.16);AI作为备用工具时召回率增加(33.6%;P<0.001),每次检查敏感度(66.4%;P<0.001)和平均解读时间(225秒;P = 0.001)增加,每次检查特异度更低(79.9%;P<0.001)。在这些场景中,只有AI作为预筛查工具显示出比不使用AI的解读更高的净效益;AI作为助手时净效益最低。不同的AI实施方法产生不同的结果。研究结果支持将AI作为预筛查工具作为首选场景。一种放射科医生仅解读AI结果为阳性的LDCT检查的方法可以在保持敏感度的同时减轻放射科医生的工作量。

相似文献

1
Artificial Intelligence for Low-Dose CT Lung Cancer Screening: Comparison of Utilization Scenarios.用于低剂量CT肺癌筛查的人工智能:应用场景比较
AJR Am J Roentgenol. 2025 Jul;225(1):e2532829. doi: 10.2214/AJR.25.32829. Epub 2025 Apr 16.
2
Real-World Diagnostic Performance and Clinical Utility of Artificial Intelligence-Assisted Interpretation for Detection of Lung Metastasis on CT in Patients With Colorectal Cancer.人工智能辅助解读在结直肠癌患者CT检测肺转移中的真实世界诊断性能及临床应用价值
AJR Am J Roentgenol. 2025 Sep 3:1-12. doi: 10.2214/AJR.25.33063.
3
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描(LDCT)筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
4
External Validation of an Upgraded AI Model for Screening Ileocolic Intussusception Using Pediatric Abdominal Radiographs: Multicenter Retrospective Study.使用儿科腹部X光片筛查回结肠套叠的升级人工智能模型的外部验证:多中心回顾性研究
J Med Internet Res. 2025 Jul 8;27:e72097. doi: 10.2196/72097.
5
Influence of AI Decision Support on Radiologists' Performance and Visual Search in Screening Mammography.人工智能决策支持对乳腺钼靶筛查中放射科医生表现及视觉搜索的影响
Radiology. 2025 Jul;316(1):e243688. doi: 10.1148/radiol.243688.
6
Implementation of an AI Algorithm in Clinical Practice to Reduce Missed Incidental Pulmonary Embolisms on Chest CT and Its Impact on Short-Term Survival.在临床实践中实施人工智能算法以减少胸部CT上遗漏的偶然肺栓塞及其对短期生存的影响。
Invest Radiol. 2025 Apr 1;60(4):260-266. doi: 10.1097/RLI.0000000000001122. Epub 2024 Oct 9.
7
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
Precision Medicine in Lung Cancer Screening: A Paradigm Shift in Early Detection-Precision Screening for Lung Cancer.肺癌筛查中的精准医学:早期检测的范式转变——肺癌精准筛查
Diagnostics (Basel). 2025 Jun 19;15(12):1562. doi: 10.3390/diagnostics15121562.